Sanae Midorikawa
Overview
Explore the profile of Sanae Midorikawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
675
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Midorikawa S, Ohtsuru A, Takano T, Schnadig V, Rogers W
EClinicalMedicine
. 2025 Feb;
80:103058.
PMID: 39896878
No abstract available.
2.
Midorikawa S, Ohtsuru A
BMC Cancer
. 2022 Mar;
22(1):235.
PMID: 35241012
Background: Overdiagnosis of thyroid cancer has become a major global medical issue. Ultrasound-based thyroid cancer screening has promoted overdiagnosis, and recently international recommendations state that it should not be conducted,...
3.
Yasui K, Takebayashi Y, Motoya R, Aoki S, Horiuchi T, Hatsuzawa T, et al.
J Radiol Prot
. 2021 May;
41(4).
PMID: 34034244
Various studies have investigated radiation risk perceptions after the accident at the Fukushima Daiichi Nuclear Power Station. However, student surveys are limited. This study aimed to investigate the perception of...
4.
Ohtsuru A, Midorikawa S
J Radiat Res
. 2021 May;
62(Supplement_1):i64-i70.
PMID: 33978183
The complex disaster of the Great East Japan Earthquake and the Fukushima nuclear accident caused concern about their various health impacts. Many types of intervention are desired as a countermeasure,...
5.
Oughton D, Liutsko L, Midorikawa S, Pirard P, Schneider T, Tomkiv Y
Environ Int
. 2021 Apr;
153:106537.
PMID: 33823460
Many radiation protection actions carry a multitude of direct and indirect consequences that can impact on the welfare of affected populations. Health surveillance raises ethical challenges linked to privacy and...
6.
Midorikawa S, Ohtsuru A
Endocr J
. 2020 Nov;
67(12):1253-1255.
PMID: 33229818
No abstract available.
7.
Takahashi H, Yasumura S, Takahashi K, Ohira T, Ohtsuru A, Midorikawa S, et al.
Medicine (Baltimore)
. 2020 Jul;
99(27):e20440.
PMID: 32629628
Since Fukushima nuclear accident in 2011, thyroid ultrasound examinations have been conducted. The first full-scale examination detected 71 thyroid-cancer cases. This study examined whether radiation exposure was associated with thyroid-cancer...
8.
Tanaka T, Satoh F, Ujihara M, Midorikawa S, Kaneko T, Takeda T, et al.
Endocr J
. 2020 May;
67(8):841-852.
PMID: 32378529
This phase 2, single-arm, open-label, dose-titration, multicenter study evaluated osilodrostat (11β-hydroxylase inhibitor) in Japanese patients with endogenous Cushing's syndrome (CS) caused by adrenal tumor/hyperplasia or ectopic adrenocorticotropic hormone syndrome. The...
9.
Ito Y, Suzuki S, Matsumoto Y, Ohkouchi C, Suzuki S, Iwadate M, et al.
Thyroid Res
. 2020 May;
13:4.
PMID: 32377234
Background: Thyrotoxicosis is common disorder among endocrine dysfunctions. It is not rare that the free thyroid hormone level exceeds the measurement range of immunoassay. Such extreme high concentration of free...
10.